Palifermin decreases severe oral mucositis of patients undergoing postoperative radiochemotherapy for head and neck cancer: A randomized, placebo-controlled trial

Journal of Clinical Oncology

Volumn 29, Issue 20, 2011, Pages 2815-2820

  Henke, Michael ^{a,b,c,d,e,f,g,h,i}   Alfonsi, Marc ^{a,b,c,d,e,f,g,h,i}   Foa, Paolo ^{a,b,c,d,e,f,g,h,i}   Giralt, Jordi ^{a,b,c,d,e,f,g,h,i}   Bardet, Etienne ^{a,b,c,d,e,f,g,h,i}   Cerezo, Laura ^{a,b,c,d,e,f,g,h,i}   Salzwimmer, Michaela ^{a,b,c,d,e,f,g,h,i}   Lizambri, Richard ^{a,b,c,d,e,f,g,h,i}   Emmerson, Lara ^{a,b,c,d,e,f,g,h,i}   Chen, Mon Gy ^{a,b,c,d,e,f,g,h,i}   Berger, Dietmar ^{a,b,c,d,e,f,g,h,i}  

^a UNIVERSITY OF FREIBURG   (Germany)

^b INSTITUT SAINTE CATHERINE   (France)

^c Centre Regional de Lutte Contre le Cancer   (France)

^d UNIVERSITY OF MILAN   (Italy)

^e HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^f HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^g UNIVERSITY HOSPITAL GRAZ   (Austria)

^h AMGEN INC   (United States)

ⁱ AMGEN LTD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; PALIFERMIN; PLACEBO;

ABDOMINAL PAIN; ADULT; ARTICLE; ASTHENIA; BACKACHE; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CHEMORADIOTHERAPY; CONTROLLED STUDY; DEHYDRATION; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG INDUCED HEADACHE; DYSPHAGIA; FATIGUE; FEBRILE NEUTROPENIA; FEMALE; FOLLOW UP; HEAD AND NECK CANCER; HEAD AND NECK CARCINOMA; HUMAN; HYPOPHARYNX CARCINOMA; INSOMNIA; LARYNX CARCINOMA; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; MUCOSA INFLAMMATION; MULTICENTER STUDY; OROPHARYNX CARCINOMA; PRIORITY JOURNAL; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; TREATMENT RESPONSE;

ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; CISPLATIN; DOUBLE-BLIND METHOD; DRUG TOXICITY; FEMALE; FIBROBLAST GROWTH FACTOR 7; HEAD AND NECK NEOPLASMS; HUMANS; INTENTION TO TREAT ANALYSIS; MALE; MIDDLE AGED; RADIOTHERAPY, ADJUVANT; RECOMBINANT PROTEINS; STOMATITIS; SURVIVAL ANALYSIS;

EID: 79960202594     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2010.32.4103     Document Type: Article

References (29)

1. NCCN Clinical Practice Guidelines in Ocology. Head and Neck Cancers. Version 2.2008. http://www.nccn.org
2. Bernier J, Domenge C, Ozsahin M, et al: Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 350:1945-1952, 2004
3. Cooper JS, Pajak TF, Forastiere AA, et al: Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 350:1937-1944, 2004
4. Rosenthal DI: Consequences of mucositis-induced treatment breaks and dose reductions on head and neck cancer treatment outcomes. J Support Oncol 5:23-31, 2007 (suppl 4)
5. Sonis ST, Elting LS, Keefe D, et al: Perspectives on cancer therapy-induced mucosal injury: Pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 100:1995-2025, 2004 (suppl)
6. Elting LS, Cooksley C, Chambers M, et al: The burdens of cancer therapy: Clinical and economic outcomes of chemotherapy-induced mucositis. Cancer 98:1531-1539, 2003 (Pubitemid 37151510)
7. Vera-Llonch M, Oster G, Hagiwara M, et al: Oral mucositis in patients undergoing radiation treatment for head and neck carcinoma. Cancer 106:329-336, 2006 (Pubitemid 43100441)
8. Keefe DM, Schubert MM, Elting LS, et al: Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer 109:820-831, 2007 (Pubitemid 46335677)
9. Peterson DE, Bensadoun RJ, Roila F: Management of oral and gastrointestinal mucositis: ESMO clinical recommendations. Ann Oncol 20:174-177, 2009 (suppl 4)
10. Quinn B, Potting CM, Stone R, et al: Guidelines for the assessment of oral mucositis in adult chemotherapy, radiotherapy and haematopoietic stem cell transplant patients. Eur J Cancer 44:61-72, 2008 (Pubitemid 350256936)
11. Rubin JS, Osada H, Finch PW, et al: Purification and characterization of a newly identified growth factor specific for epithelial cells. Proc Natl Acad Sci U S A 86:802-806, 1989 (Pubitemid 19056244)
12. Finch PW, Rubin JS: Keratinocyte growth factor/fibroblast growth factor 7, a homeostatic factor with therapeutic potential for epithelial protection and repair. Adv Cancer Res 91:69-136, 2004 (Pubitemid 39140957)
13. Spielberger R, Stiff P, Bensinger W, et al: Palifermin for oral mucositis after intensive therapy for hematologic cancers. N Engl J Med 351:2590-2598, 2004 (Pubitemid 39628580)
14. Brizel DM, Murphy BA, Rosenthal DI, et al: Phase II study of palifermin and concurrent chemoradiation in head and neck squamous cell carcinoma. J Clin Oncol 26:2489-2496, 2008
15. Henke M, Laszig R, Rübe C, et al: Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: Randomised, double-blind, placebo-controlled trial. Lancet 362:1255-1260, 2003 (Pubitemid 37324251)
16. Epstein JB, Beaumont JL, Gwede CK, et al: Longitudinal evaluation of the oral mucositis weekly questionnaire-head and neck cancer, a patient-reported outcomes questionnaire. Cancer 109:1914-1922, 2007
17. Mantel N, Haenszel W: Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719-748, 1959
18. 2 tests. Biometrics 10:417-451, 1954
19. van Elteren PH: On the combination of independent two-sample tests of Wilcoxon. Bulletin Intl Stat Inst 37:351-361, 1960
20. Lachenbruch PA: Analysis of data with clumping at zero. Biometr Z 18:351-356, 1976
21. Hochberg Y: A sharper Bonferroni procedure for multiple tests of significance. Biometrika 75:800-802, 1988
22. Kaplan EL, Meier P: Non parametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
23. Le Q-T, Kim HE, Schneider CJ, et al: Palifermin reduces severe mucositis in definitive chemoradiotherapy of locally advanced head and neck cancer. A randomized, placebo-controlled study. J Clin Oncol 29:2808-2814, 2011
24. Rosen LS, Abdi E, Davis ID, et al: Palifermin reduces the incidence of oral mucositis in patients with metastatic colorectal cancer treated with fluorouracil-based chemotherapy. J Clin Oncol 24:5194-5200, 2006 (Pubitemid 46631362)
25. Stiff PJ, Emmanouilides C, Bensinger WI, et al: Palifermin reduces patient-reported mouth and throat soreness and improves patient functioning in the hematopoietic stem-cell transplantation setting. J Clin Oncol 24:5186-5193, 2006 (Pubitemid 46646481)
26. Brizel DM, Wasserman TH, Henke M, et al: Phase III randomized trial of amifostine as a radioprotector in head and neck cancer. J Clin Oncol 18:3339-3345, 2000
27. Dörr W, Reichel S, Spekl K: Effects of keratinocyte growth factor (palifermin) administration protocols on oral mucositis (mouse) induced by fractionated irradiation. Radiother Oncol 75:99-105, 2005 (Pubitemid 40616801)
28. Eisbruch A, Schwartz M, Rasch C, et al: Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: Which anatomic structures are affected and can they be spared by IMRT? Int J Radiat Oncol Biol Phys 60:1425-1439, 2004
29. Huang WY, Jen YM, Chen CM, et al: Intensity modulated radiotherapy with concurrent chemotherapy for larynx preservation of advanced resectable hypopharyngeal cancer. Radiat Oncol 5:37, 2010